Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

View source ↗

Summary

This clinical trial update analyzes the cost profile and budget implications of rechargeable versus non-rechargeable sacral neuromodulation devices for neurogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Rechargeable Sacral Neuromodulation Device, Neurogenic Lower Urinary Tract Dysfunction | Status: NOT_YET_RECRUITING